Clinical Trial Update: Right to Left Cardiac Shunt Detection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating detection of right-to-left cardiac shunts has been terminated, involving patent foramen ovale and atrial septal defect.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Patent Foramen Ovale

Snippet

Sponsor: Cardiox Corporation | Conditions: Right to Left Shunt, Patent Foramen Ovale | Phase 3 | Status: TERMINATED